Beauveria bassiana (Balsamo-Vuillemin), an effective entomopathogenic fungi is well positioned in the biological control of insect pests for more than ten decades around the world. Its potential can be attributed to the fungus’s entry through several parts of the insect and its mode of action. But sometimes a virulent strain of B. bassiana may become ineffective because of xenobiotics and environmental factors. To enhance the efficacy of B. bassiana, which is necessary for placing it in Integrated Pest Management, the Colony Forming Unit (CFU) of B. bassiana should be compatible with xenobiotics used in crop production. The compatible concentrations of imidacloprid 48% FS (500 ppm) for B. bassiana was studied in the laboratory condition and results revealed low per cent growth inhibition (21.25%) and maximum radial growth (1.46 cm) at 15 Days After Inoculation (DAI). The inhibition of colony growth was reduced by treating the bhendi seeds with B. bassiana and imidacloprid 48 % FS at a time interval of four hours which showed high mean colony growth (51.12).
A study on parasitization percentage of Bracon hebetor Say on certain lepidopteran insect pest on Rice moth (Corcyra cephalonica Stainton), Tomato fruit borer (Helicoverpa armigera Hubner),Tobacco leaf eating caterpillar (Spodoptera litura Fabricius) and okra fruit borer (Earias vitella Fabricius), studied at ordinary room temperature under invitro conditions and revealed that C. cephalonica was the most suitable host for the development of B. hebetor among the host species tested regarding the parasitization percentage was high in C. cephalonica followed by S. litura, H. armigera and E. vitella.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.